Tobacco Company working on potential COVID-19 vaccine

01 April 2020 Potential vaccine in development for COVID-19 using new, fast-growing tobacco plant technology – pre-clinical testing under way Tobacco plants offer the potential for faster and safer vaccine development compared to conventional methods Potential to manufacture 1-3 million doses of vaccine per week BAT’s US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for COVID-19 and is now in pre-clinical testing. If testing goes well, BAT is hopeful that, with the … Read More